/EpiLN

Identification of a epigenetic-based signature to identify breast cancer patients with lymph node involvement

Primary LanguageR

EpiLN

Identification of a epigenetic-based signature to identify breast cancer patients with lymph node involvement using Random Forest algorithms

Ensenyat-Mendez, M., Rünger, D., Orozco, J. I., Le, J., Baker, J. L., Weidhaas, J., ... & DiNome, M. L. (2022). Epigenetic signatures predict pathologic nodal stage in breast cancer patients with estrogen receptor-positive, clinically node-positive disease. Annals of Surgical Oncology, 1-9. https://link.springer.com/article/10.1245/s10434-022-12143-6